ClinfoSource and Quintiles Transnational Sign Licensing Agreement for Clinical Research Training

Share Article

ClinfoSource (http://www.clinfosource.com), provider of online Good Clinical Practice (GCP) training for clinical research professionals, has entered into a licensing agreement with Quintiles Transnational Corporation (Quintiles). Under the terms of the agreement, ClinfoSource will grant Quintiles licensing rights to use its GCP course content for the internal training of Quintiles employees worldwide.

Quintiles is a global leader in pharmaceutical services and it is our privilege to offer a quality training program for its employees around the world

ClinfoSource (http://www.clinfosource.com), provider of online Good Clinical Practice (GCP) training for clinical research professionals, has entered into a licensing agreement with Quintiles Transnational Corporation (Quintiles). Under the terms of the agreement, ClinfoSource will grant Quintiles licensing rights to use its GCP course content for the internal training of Quintiles employees worldwide.

"Quintiles is a global leader in pharmaceutical services and it is our privilege to offer a quality training program for its employees around the world", said Dr. Kay Ranganathan, President of ClinfoSource. "We are confident and delighted that our training courses will contribute solidly towards Quintiles' continued commitment to enhancing their regulatory and corporate compliance".

Tim Toterhi, Director, Global L&D Strategies and Solutions, Quintiles Transnational said, "Regulatory compliance is part of our culture. We live and breathe GCP every day. Through this agreement we can further enhance our world-class global training program. We have previewed ClinfoSource's program and are impressed with their course content, which is an ideal fit for clinical research training."

About ClinfoSource

Headquartered in Danville, CA, ClinfoSource provides comprehensive and easy to use GCP training and automated training documentation system for clinical research professionals. ClinfoSource's program is used by pharmaceutical and biotechnology companies, Contract Research Organizations (CROs), medicals schools, Clinical Research Organizations and Investigational Site personnel around the world. The program addresses various aspects of clinical research conduct and management in accordance with FDA regulations and international guidelines, and discusses the practical aspects and ethical considerations inherent to the drug development process. For more information about ClinfoSource please visit http://www.clinfosource.com.

About Quintiles

Quintiles Transnational Corp. is powering the next generation of healthcare by providing a broad range of professional services in drug development, information, financial partnering and commercialization for the pharmaceutical and biotechnology industries. With 16,000 employees and offices in more than 50 countries, it is focused on providing customer-centric solutions that are the gold standard of the industry. For more information, please visit the company's Web site at http://www.quintiles.com.

For further information contact:

Ranga Nathan

Director, Marketing

ClinfoSource

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ranga Nathan
Visit website